Weekly Buzz: So far, Santa is Letting us Down
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
Assembly Bio Spikes After Early-stage Data for Gilead-partnered Hep B Therapy
Mizuho CEO Sees Global Boom in M&A After Trump Takes Office
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Needham Reiterates Hold on Neurocrine Biosciencesto Hold
Neurocrine Biosciences Analyst Ratings
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
(GILD) - Analyzing Gilead Sciences's Short Interest
Gilead Raises Assembly Bio Stake to ~30%
Argenx Analyst Ratings
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Peering Into Exelixis's Recent Short Interest
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
$1000 Invested In Argenx 5 Years Ago Would Be Worth This Much Today
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today